Total Equity
Amgen Total Equity increased by 6.1% to $9.19B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 48.1%, from $6.21B to $9.19B. Over 5 years (FY 2020 to FY 2025), Total Equity shows relatively stable performance with a -1.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increasing trend generally signals strong profitability and capital retention, while a decreasing trend may indicate share buybacks, dividend payouts, or net losses.
Detailed definition
Total stockholders' equity represents the residual interest in the assets of the company after deducting all liabilities...
Peer comparison
A fundamental balance sheet metric used universally to assess the financial foundation and solvency of a corporation.
total_stockholders_equityHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.25B | $8.22B | $6.70B | $916.00M | $2.42B | $3.65B | $3.66B | $5.35B | $6.78B | $7.66B | $6.23B | $5.02B | $5.93B | $7.53B | $5.88B | $6.21B | $7.43B | $9.62B | $8.66B | $9.19B |
| QoQ Change | — | -0.4% | -18.5% | -86.3% | +164.1% | +51.0% | +0.2% | +46.1% | +26.8% | +12.9% | -18.6% | -19.4% | +18.0% | +27.0% | -21.9% | +5.6% | +19.7% | +29.5% | -10.0% | +6.1% |
| YoY Change | — | — | — | — | -70.7% | -55.5% | -45.4% | +483.8% | +180.3% | +109.6% | +70.2% | -6.1% | -12.6% | -1.7% | -5.7% | +23.6% | +25.4% | +27.8% | +47.3% | +48.1% |
Total Equity at Other Companies
Frequently Asked Questions
- What is Amgen's total equity?
- Amgen (AMGN) reported total equity of $9.19B in Q1 2026.
- How has Amgen's total equity changed year-over-year?
- Amgen's total equity increased by 48.1% year-over-year, from $6.21B to $9.19B.
- What is the long-term trend for Amgen's total equity?
- Over 5 years (2020 to 2025), Amgen's total equity has grown at a -1.6% compound annual growth rate (CAGR), from $9.41B to $8.66B.
- What does total equity mean?
- The net value of the company belonging to shareholders, calculated as total assets minus total liabilities.